Literature DB >> 8581074

Liver disturbances in obesity and diabetes mellitus.

W Van Steenbergen1, S Lanckmans.   

Abstract

Abnormal liver tests, right upper quadrant pain and hepatomegaly occurring in an obese or in a diabetic patient may point to the presence of fat or of glycogen accumulation in the liver parenchymal cells. Marked hepatomegaly due to cytoplasmic glycogen deposition is mainly found in poorly controlled insulin-dependent diabetic patients. If accompanied by cushingoid features, growth retardation and by delayed puberty, a diagnosis of Mauriac syndrome can be made. Hyperglycaemia, insulin administration and increased concentrations of the counterregulatory hormone cortisol may all play a role in the glycogen deposition by their concerted actions on the glycogen phosphorylase and synthase enzymes, promoting the accumulation of glycogen. Hypercortisolism may be responsible for growth retardation and delayed puberty in Mauriac patients. Regression of hepatomegaly and of the associated clinical characteristics may be obtained by a better metabolic control due to the administration of long-acting insulin and the change from single to twice daily injections. Fatty liver is rare in insulin-dependent diabetic patients and is indicative of a poor diabetic control. This process is quickly reversible by adequate insulin treatment. Steatosis is frequently found in maturity-onset diabetics and in obese patients. The pathogenetic mechanisms leading to the accumulation of triglycerides and of fatty acids in the hepatocytes can easily be understood from the normal cycling of fatty acids between the adiopose tissue and the liver. Histologic features of nonalcoholic steatohepatitis can also be found in obese and in diabetic patients. Steatohepatitis may rarely evolve into cirrhosis. In general, there is no correlation between the degree of the biochemical alterations and the severity of the histological findings.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8581074

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  19 in total

1.  Nutritional and metabolic considerations in the etiology of nonalcoholic steatohepatitis.

Authors:  V Nehra; P Angulo; A L Buchman; K D Lindor
Journal:  Dig Dis Sci       Date:  2001-11       Impact factor: 3.199

2.  Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting.

Authors:  S Kersten; J Seydoux; J M Peters; F J Gonzalez; B Desvergne; W Wahli
Journal:  J Clin Invest       Date:  1999-06       Impact factor: 14.808

3.  Bariatric Surgery in Cirrhotic Patients: Is It Safe?

Authors:  Hafsa Younus; Amit Sharma; Rosa Miquel; Alberto Quaglia; Subba Rao Kanchustambam; Kirstin A Carswell; Ameet G Patel
Journal:  Obes Surg       Date:  2020-04       Impact factor: 4.129

Review 4.  Multicausality in fatty liver disease: is there a rationale to distinguish between alcoholic and non-alcoholic origin?

Authors:  Henry Völzke
Journal:  World J Gastroenterol       Date:  2012-07-21       Impact factor: 5.742

Review 5.  Hepatotoxicity with thiazolidinediones: is it a class effect?

Authors:  A J Scheen
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

6.  Liver-specific reactivation of the inactivated Hnf-1alpha gene: elimination of liver dysfunction to establish a mouse MODY3 model.

Authors:  Ying-Hue Lee; Mark A Magnuson; Vijayakumar Muppala; Shih-Shun Chen
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

7.  Alterations in liver sinusoidal endothelium in a baboon model of type 1 diabetes.

Authors:  H A Jamieson; V C Cogger; S M Twigg; S V McLennan; A Warren; R Cheluvappa; S N Hilmer; R Fraser; R de Cabo; D G Le Couteur
Journal:  Diabetologia       Date:  2007-06-29       Impact factor: 10.122

Review 8.  Metabolic complications of obesity.

Authors:  S M Grundy
Journal:  Endocrine       Date:  2000-10       Impact factor: 3.925

9.  Glycogen hepatopathy in a 13-year-old male with type 1 diabetes.

Authors:  Khalid S Aljabri; Samia A Bokhari; Sanaa M Fageeh; Abdullah M Alharbi; Mohamad A Abaza
Journal:  Ann Saudi Med       Date:  2011 Jul-Aug       Impact factor: 1.526

10.  The CEACAM1 expression is decreased in the liver of severely obese patients with or without diabetes.

Authors:  Wonae Lee
Journal:  Diagn Pathol       Date:  2011-05-11       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.